The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Midterm Local Efficacy and Survival after Radiofrequency Ablation of Lung Tumors with Minimum Follow-up of 1 Year: Prospective Evaluation
Abstract
PURPOSE: To prospectively evaluate the local efficacy of radiofrequency (RF) ablation of lung neoplasms, with a minimum follow-up period of 1 year. MATERIALS AND METHODS: Sixty patients (34 men and 26 women; age range, 27-81 years; mean age, 66 years) with 100 lung tumors gave written informed consent to be enrolled in a prospective study that was approved by the local ethics committee. There were five or fewer tumors per patient, each with a diameter of less than 40 mm (mean +/- standard deviation, 17 mm +/- 10). RF ablation was performed in tumors by using computed tomographic (CT) guidance. Follow-up CT studies were obtained within 48 hours after treatment and at 2, 4, 6, 9, and 12 months thereafter to evaluate treatment outcome and complications. Lung spirometry measurements were obtained before and 4 weeks after RF ablation. RESULTS: Ninety-seven of 100 targeted tumors were treated and required 163 RF ablations (1.68 per tumor), each lasting 14 minutes +/- 8, delivered during 74 procedures. The 18-month estimated rate of incomplete local treatment at CT was 7% (95% confidence interval: 3%, 14%) per tumor and 12% (95% confidence interval: 5%, 23%) per patient. An ablation area at least four times larger than the initial tumor was predictive of complete ablation treatment (P = .02). There was a trend toward better efficacy for tumors smaller than 2 cm in diameter (P = .066). Overall survival and lung disease-free survival at 18 months were 71% and 34%, respectively. The main adverse event was a pneumothorax, which occurred in 54% of procedures, but a chest tube was required in only 9% of the procedures. No modification of respiratory function was found when spirometry measurements obtained before and within 2 months after RF ablation were compared (P = .51). CONCLUSION: RF ablation has a high local efficacy and is well tolerated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Optimal two-stage designs for phase II clinical trials.
Simon, R. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90015-9 · Cited by 3,636
Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases
Pastorino, U., Buyse, M., Friedel, G., Ginsberg, R. J., Girard, P., Goldstraw, P., Johnston, M., McCormack, P., Pass, H., & Putnam, J. B. (1997) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(97)70397-0 · Cited by 1,529
Lencioni, R. A., Allgaier, H.-P., Cioni, D., Olschewski, M., Deibert, P., Crocetti, L., Frings, H., Laubenberger, J., Zuber, I., Blum, H. E., et al. (2003) · Radiology · doi:10.1148/radiol.2281020718 · Cited by 998
Solbiati, L., Livraghi, T., Goldberg, S. N., Ierace, T., Meloni, F., Dellanoce, M., Cova, L., Halpern, E. F., & Gazelle, G. S. (2001) · Radiology · doi:10.1148/radiol.2211001624 · Cited by 870
Radiofrequency Ablation of 100 Hepatic Metastases with a Mean Follow-Up of More Than 1 Year
de Baere, T., Elias, D., Dromain, C., Din, M. G. E., Kuoch, V., Ducreux, M., Boige, V., Lassau, N., Marteau, V., Lasser, P., et al. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.175.6.1751619 · Cited by 393
Self-citationKodama, K., Doi, O., Higashiyama, M., & Yokouchi, H. (1997) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(97)70179-x · Cited by 343
Percutaneous Radiofrequency Ablation of Lung Neoplasms: Initial Therapeutic Response
Akeboshi, M., Yamakado, K., Nakatsuka, A., Hataji, O., Taguchi, O., Takao, M., & Takeda, K. (2004) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000126812.12853.77 · Cited by 213
Schaefer, J. F., Vollmar, J., Schick, F., Vonthein, R., Seemann, M. D., Aebert, H., Dierkesmann, R., Friedel, G., & Claussen, C. D. (2004) · Radiology · doi:10.1148/radiol.2322030515 · Cited by 179
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Treatment of Stage I and II Non-small Cell Lung Cancer
Howington, J. A., Blum, M. G., Chang, A. C., Balekian, A. A., & Murthy, S. C. (2013) · Chest · doi:10.1378/chest.12-2359 · Cited by 1,440
Callister, M. E. J., Baldwin, D. R., Akram, A. R., Barnard, S., Cane, P., Draffan, J., Franks, K., Gleeson, F., Graham, R., Malhotra, P., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207168 · Cited by 958
Lencioni, R., Crocetti, L., Cioni, R., Suh, R., Glenn, D., Regge, D., Helmberger, T., Gillams, A. R., Frilling, A., Ambrogi, M., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70155-4 · Cited by 532
Microwave Ablation of Lung Malignancies: Effectiveness, CT Findings, and Safety in 50 Patients
Wolf, F. J., Grand, D. J., Machan, J. T., DiPetrillo, T. A., Mayo-Smith, W. W., & Dupuy, D. E. (2008) · Radiology · doi:10.1148/radiol.2473070996 · Cited by 398
Metadata
- Authors
- Baère, T. D., Palussière, J., Aupérin, A., Hakime, A., Abdel-Rehim, M., Kind, M., Dromain, C., Ravaud, A., Tebboune, N., Boige, V., Malka, D., Lafont, C., & Ducreux, M.
- Venue
- Radiology
- Published
- 2006-08
- Volume
- 240
- Issue
- 2
- Pages
- 587-596
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2097508883
- Cited by
- 343
- References
- 8
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.